Sample Name	Source Name	Characteristics[Organism]	Term Source REF	Term Accession Number	Characteristics[gender]	Characteristics[disease]	Protocol REF	Parameter Value[physiological stage]	Source Name	Sample Name	Characteristics[Organism part]	Term Source REF	Term Accession Number	Factor Value[BMI]	Unit	Term Source REF	Term Accession Number	Factor Value[menopause status]	Term Source REF	Term Accession Number	Factor Value[Estrogen Receptor status]	Term Source REF	Term Accession Number	Factor Value[Progesterone Receptor Status]	Factor Value[Grade]	Term Source REF	Term Accession Number	Factor Value[Her2 receptor status]	Term Source REF	Term Accession Number	Factor Value[treatment supplement]	Factor Value[Lymph Node stage]	Term Source REF	Term Accession Number	Factor Value[Tumor stage]	Term Source REF	Term Accession Number	Factor Value[treatment arm]	Factor Value[collection timepoint]	Term Source REF	Term Accession Number	Factor Value[cohort]	Term Source REF	Term Accession Number	Factor Value[Chemotherapy response]	Term Source REF	Term Accession Numberserum_A_1	A_1	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_1	serum_A_1	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	35	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			3			"1= 4_ epirubicine, cyclophosphamide followed_by docetaxel"	before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_2	A_2	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_2	serum_A_2	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				1			2			"2= 4_ epirubicine, cyclophosphamide followed_by docetaxel,capecitabine"	before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_3	A_3	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_3	serum_A_3	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				2			5			"3= 4_ epirubicine, cyclophosphamide followed_by docetaxel followed_by capecitabine"	before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_4	A_4	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_4	serum_A_4	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	33	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				1			negative				1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_5	A_5	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_5	serum_A_5	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	33	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_6	A_6	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_6	serum_A_6	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_7	A_7	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_7	serum_A_7	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_8	A_8	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_8	serum_A_8	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			5				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_10	A_10	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_10	serum_A_10	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	18	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_11	A_11	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_11	serum_A_11	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_12	A_12	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_12	serum_A_12	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_14	A_14	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_14	serum_A_14	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			4				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_16	A_16	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_16	serum_A_16	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_17	A_17	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_17	serum_A_17	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				1			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_18	A_18	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_18	serum_A_18	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_19	A_19	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_19	serum_A_19	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_20	A_20	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_20	serum_A_20	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				2			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_21	A_21	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_21	serum_A_21	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_22	A_22	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_22	serum_A_22	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				2			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_24	A_24	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_24	serum_A_24	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	3			4				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_25	A_25	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_25	serum_A_25	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_26	A_26	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_26	serum_A_26	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive							positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_27	A_27	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_27	serum_A_27	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_28	A_28	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_28	serum_A_28	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_29	A_29	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_29	serum_A_29	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				1			1				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_30	A_30	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_30	serum_A_30	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				1			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_31	A_31	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_31	serum_A_31	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				1			negative				1			4				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_32	A_32	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_32	serum_A_32	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			3				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_33	A_33	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_33	serum_A_33	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				0			4				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_34	A_34	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_34	serum_A_34	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	32	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_35	A_35	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_35	serum_A_35	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				2			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_36	A_36	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_36	serum_A_36	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_37	A_37	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_37	serum_A_37	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_39	A_39	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_39	serum_A_39	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_40	A_40	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_40	serum_A_40	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_41	A_41	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_41	serum_A_41	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_42	A_42	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_42	serum_A_42	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_43	A_43	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_43	serum_A_43	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_44	A_44	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_44	serum_A_44	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_45	A_45	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_45	serum_A_45	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_46	A_46	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_46	serum_A_46	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	1			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_47	A_47	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_47	serum_A_47	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_48	A_48	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_48	serum_A_48	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	40	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				3			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_49	A_49	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_49	serum_A_49	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	34	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				3			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_52	A_52	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_52	serum_A_52	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_53	A_53	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_53	serum_A_53	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_54	A_54	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_54	serum_A_54	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_55	A_55	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_55	serum_A_55	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	36	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_56	A_56	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_56	serum_A_56	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_57	A_57	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_57	serum_A_57	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive							negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_58	A_58	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_58	serum_A_58	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_61	A_61	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_61	serum_A_61	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_62	A_62	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_62	serum_A_62	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_64	A_64	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_64	serum_A_64	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_65	A_65	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_65	serum_A_65	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_66	A_66	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_66	serum_A_66	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_67	A_67	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_67	serum_A_67	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_68	A_68	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_68	serum_A_68	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_69	A_69	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_69	serum_A_69	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_70	A_70	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_70	serum_A_70	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			5				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_71	A_71	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_71	serum_A_71	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive							negative				1			5				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_73	A_73	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_73	serum_A_73	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_74	A_74	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_74	serum_A_74	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_76	A_76	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_76	serum_A_76	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_79	A_79	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_79	serum_A_79	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_80	A_80	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_80	serum_A_80	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive							positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_81	A_81	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_81	serum_A_81	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_82	A_82	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_82	serum_A_82	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_85	A_85	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_85	serum_A_85	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				1			5				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_86	A_86	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_86	serum_A_86	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_189	A_189	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_189	serum_A_189	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_211	A_211	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_211	serum_A_211	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_212	A_212	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_212	serum_A_212	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				1			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_213	A_213	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_213	serum_A_213	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_214	A_214	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_214	serum_A_214	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				1			5				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_216	A_216	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_216	serum_A_216	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				1			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_217	A_217	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_217	serum_A_217	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	35	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_219	A_219	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_219	serum_A_219	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	35	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_220	A_220	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_220	serum_A_220	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	1			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_221	A_221	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_221	serum_A_221	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_223	A_223	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_223	serum_A_223	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_225	A_225	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_225	serum_A_225	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				0			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_226	A_226	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_226	serum_A_226	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_227	A_227	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_227	serum_A_227	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	40	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				0			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_228	A_228	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_228	serum_A_228	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_229	A_229	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_229	serum_A_229	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_230	A_230	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_230	serum_A_230	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_231	A_231	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_231	serum_A_231	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_232	A_232	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_232	serum_A_232	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			positive			trastuzumab	2			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_233	A_233	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_233	serum_A_233	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_234	A_234	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_234	serum_A_234	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	37	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	2			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_235	A_235	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_235	serum_A_235	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_237	A_237	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_237	serum_A_237	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_238	A_238	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_238	serum_A_238	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_239	A_239	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_239	serum_A_239	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			positive			trastuzumab	2			5				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_240	A_240	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_240	serum_A_240	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	2			3				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_242	A_242	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_242	serum_A_242	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_243	A_243	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_243	serum_A_243	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	32	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	1			5				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_244	A_244	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_244	serum_A_244	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_246	A_246	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_246	serum_A_246	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	1			1				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_247	A_247	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_247	serum_A_247	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	33	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_248	A_248	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_248	serum_A_248	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	19	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_249	A_249	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_249	serum_A_249	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_250	A_250	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_250	serum_A_250	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				1			negative				1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_251	A_251	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_251	serum_A_251	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_252	A_252	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_252	serum_A_252	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_254	A_254	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_254	serum_A_254	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_255	A_255	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_255	serum_A_255	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_258	A_258	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_258	serum_A_258	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive							positive			trastuzumab	1			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_259	A_259	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_259	serum_A_259	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	38	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_262	A_262	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_262	serum_A_262	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_263	A_263	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_263	serum_A_263	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_264	A_264	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_264	serum_A_264	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			1				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_265	A_265	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_265	serum_A_265	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	0			3				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_266	A_266	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_266	serum_A_266	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_268	A_268	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_268	serum_A_268	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			3				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_269	A_269	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_269	serum_A_269	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_270	A_270	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_270	serum_A_270	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_272	A_272	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_272	serum_A_272	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	32	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				1			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_273	A_273	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_273	serum_A_273	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_274	A_274	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_274	serum_A_274	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_275	A_275	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_275	serum_A_275	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	1			3				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_276	A_276	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_276	serum_A_276	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_277	A_277	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_277	serum_A_277	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_279	A_279	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_279	serum_A_279	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_280	A_280	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_280	serum_A_280	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_281	A_281	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_281	serum_A_281	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	1			4				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_283	A_283	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_283	serum_A_283	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_284	A_284	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_284	serum_A_284	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive							positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_285	A_285	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_285	serum_A_285	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	1			1				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_287	A_287	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_287	serum_A_287	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_288	A_288	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_288	serum_A_288	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	35	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	1			3				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_289	A_289	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_289	serum_A_289	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_290	A_290	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_290	serum_A_290	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			5				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_293	A_293	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_293	serum_A_293	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_294	A_294	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_294	serum_A_294	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_295	A_295	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_295	serum_A_295	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_296	A_296	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_296	serum_A_296	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	1			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_297	A_297	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_297	serum_A_297	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			positive			trastuzumab	1			1				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_298	A_298	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_298	serum_A_298	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			pathologic complete response		serum_A_299	A_299	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_299	serum_A_299	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_300	A_300	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_300	serum_A_300	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	39	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			positive			trastuzumab	0			2				before neoadjuvant therapy			discovery cohort			no pathologic complete response		serum_A_89	A_89	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_89	serum_A_89	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_90	A_90	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_90	serum_A_90	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_91	A_91	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_91	serum_A_91	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_92	A_92	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_92	serum_A_92	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	38	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_93	A_93	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_93	serum_A_93	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_94	A_94	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_94	serum_A_94	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_95	A_95	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_95	serum_A_95	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	33	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_96	A_96	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_96	serum_A_96	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			3				after neoadjuvant therapy			discovery cohort					serum_A_97	A_97	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_97	serum_A_97	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_98	A_98	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_98	serum_A_98	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_99	A_99	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_99	serum_A_99	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_104	A_104	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_104	serum_A_104	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_105	A_105	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_105	serum_A_105	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_106	A_106	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_106	serum_A_106	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_107	A_107	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_107	serum_A_107	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_109	A_109	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_109	serum_A_109	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	32	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	1			5				after neoadjuvant therapy			discovery cohort					serum_A_110	A_110	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_110	serum_A_110	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_111	A_111	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_111	serum_A_111	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_113	A_113	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_113	serum_A_113	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			3				after neoadjuvant therapy			discovery cohort					serum_A_118	A_118	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_118	serum_A_118	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	35	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			3				after neoadjuvant therapy			discovery cohort					serum_A_120	A_120	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_120	serum_A_120	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	33	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				1			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_121	A_121	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_121	serum_A_121	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_122	A_122	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_122	serum_A_122	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_124	A_124	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_124	serum_A_124	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				2			5				after neoadjuvant therapy			discovery cohort					serum_A_125	A_125	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_125	serum_A_125	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				2			2				after neoadjuvant therapy			discovery cohort					serum_A_126	A_126	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_126	serum_A_126	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			5				after neoadjuvant therapy			discovery cohort					serum_A_128	A_128	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_128	serum_A_128	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				2			2				after neoadjuvant therapy			discovery cohort					serum_A_129	A_129	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_129	serum_A_129	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_130	A_130	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_130	serum_A_130	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_131	A_131	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_131	serum_A_131	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			4				after neoadjuvant therapy			discovery cohort					serum_A_132	A_132	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_132	serum_A_132	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_134	A_134	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_134	serum_A_134	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				1			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_136	A_136	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_136	serum_A_136	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_138	A_138	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_138	serum_A_138	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_139	A_139	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_139	serum_A_139	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	18	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_141	A_141	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_141	serum_A_141	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_142	A_142	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_142	serum_A_142	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_143	A_143	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_143	serum_A_143	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				1			negative				1			4				after neoadjuvant therapy			discovery cohort					serum_A_144	A_144	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_144	serum_A_144	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				1			1				after neoadjuvant therapy			discovery cohort					serum_A_145	A_145	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_145	serum_A_145	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				1			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_146	A_146	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_146	serum_A_146	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_147	A_147	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_147	serum_A_147	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_148	A_148	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_148	serum_A_148	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				0			4				after neoadjuvant therapy			discovery cohort					serum_A_149	A_149	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_149	serum_A_149	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	32	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_150	A_150	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_150	serum_A_150	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				2			3				after neoadjuvant therapy			discovery cohort					serum_A_151	A_151	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_151	serum_A_151	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			3				after neoadjuvant therapy			discovery cohort					serum_A_152	A_152	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_152	serum_A_152	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_154	A_154	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_154	serum_A_154	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_155	A_155	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_155	serum_A_155	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	3			4				after neoadjuvant therapy			discovery cohort					serum_A_156	A_156	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_156	serum_A_156	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			3				after neoadjuvant therapy			discovery cohort					serum_A_157	A_157	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_157	serum_A_157	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_159	A_159	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_159	serum_A_159	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_160	A_160	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_160	serum_A_160	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			3				after neoadjuvant therapy			discovery cohort					serum_A_162	A_162	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_162	serum_A_162	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			3				after neoadjuvant therapy			discovery cohort					serum_A_163	A_163	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_163	serum_A_163	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_167	A_167	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_167	serum_A_167	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_169	A_169	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_169	serum_A_169	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_170	A_170	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_170	serum_A_170	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_172	A_172	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_172	serum_A_172	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_174	A_174	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_174	serum_A_174	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_177	A_177	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_177	serum_A_177	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_179	A_179	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_179	serum_A_179	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	37	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	2			2				after neoadjuvant therapy			discovery cohort					serum_A_181	A_181	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_181	serum_A_181	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				1			5				after neoadjuvant therapy			discovery cohort					serum_A_183	A_183	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_183	serum_A_183	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	40	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				0			3				after neoadjuvant therapy			discovery cohort					serum_A_184	A_184	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_184	serum_A_184	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_186	A_186	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_186	serum_A_186	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_187	A_187	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_187	serum_A_187	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive							positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_190	A_190	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_190	serum_A_190	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_191	A_191	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_191	serum_A_191	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			3				after neoadjuvant therapy			discovery cohort					serum_A_192	A_192	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_192	serum_A_192	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_193	A_193	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_193	serum_A_193	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_194	A_194	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_194	serum_A_194	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_196	A_196	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_196	serum_A_196	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_200	A_200	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_200	serum_A_200	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133		kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	1			3				after neoadjuvant therapy			discovery cohort					serum_A_204	A_204	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_204	serum_A_204	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_205	A_205	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_205	serum_A_205	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive							negative				1			5				after neoadjuvant therapy			discovery cohort					serum_A_206	A_206	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_206	serum_A_206	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				1			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_207	A_207	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_207	serum_A_207	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				0			3				after neoadjuvant therapy			discovery cohort					serum_A_210	A_210	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_210	serum_A_210	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				after neoadjuvant therapy			discovery cohort					serum_A_302	A_302	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_302	serum_A_302	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_305	A_305	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_305	serum_A_305	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	39	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_307	A_307	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_307	serum_A_307	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	35	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	1			3				after neoadjuvant therapy			discovery cohort					serum_A_308	A_308	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_308	serum_A_308	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				1			negative				1			2				after neoadjuvant therapy			discovery cohort					serum_A_309	A_309	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_309	serum_A_309	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_310	A_310	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_310	serum_A_310	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_311	A_311	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_311	serum_A_311	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_313	A_313	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_313	serum_A_313	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_314	A_314	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_314	serum_A_314	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_315	A_315	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_315	serum_A_315	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_316	A_316	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_316	serum_A_316	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_317	A_317	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_317	serum_A_317	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	32	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				1			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_319	A_319	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_319	serum_A_319	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	1			3				after neoadjuvant therapy			discovery cohort					serum_A_320	A_320	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_320	serum_A_320	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_321	A_321	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_321	serum_A_321	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			5				after neoadjuvant therapy			discovery cohort					serum_A_322	A_322	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_322	serum_A_322	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	1			1				after neoadjuvant therapy			discovery cohort					serum_A_325	A_325	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_325	serum_A_325	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_327	A_327	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_327	serum_A_327	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_328	A_328	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_328	serum_A_328	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_330	A_330	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_330	serum_A_330	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive							positive			trastuzumab	1			3				after neoadjuvant therapy			discovery cohort					serum_A_331	A_331	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_331	serum_A_331	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_332	A_332	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_332	serum_A_332	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_333	A_333	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_333	serum_A_333	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_335	A_335	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_335	serum_A_335	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_337	A_337	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_337	serum_A_337	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	2			3				after neoadjuvant therapy			discovery cohort					serum_A_339	A_339	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_339	serum_A_339	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_340	A_340	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_340	serum_A_340	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	1			1				after neoadjuvant therapy			discovery cohort					serum_A_341	A_341	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_341	serum_A_341	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			1				after neoadjuvant therapy			discovery cohort					serum_A_343	A_343	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_343	serum_A_343	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive							positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_344	A_344	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_344	serum_A_344	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_A_349	A_349	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_349	serum_A_349	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	1			2				after neoadjuvant therapy			discovery cohort					serum_A_350	A_350	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	A_350	serum_A_350	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			positive			trastuzumab	0			2				after neoadjuvant therapy			discovery cohort					serum_B_26	B_26	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_26	serum_B_26	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_36	B_36	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_36	serum_B_36	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	33	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_52	B_52	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_52	serum_B_52	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_55	B_55	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_55	serum_B_55	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_64	B_64	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_64	serum_B_64	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				0			1				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_72	B_72	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_72	serum_B_72	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	19	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_80	B_80	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_80	serum_B_80	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_112	B_112	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_112	serum_B_112	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				2			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_128	B_128	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_128	serum_B_128	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			5				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_132	B_132	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_132	serum_B_132	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_136	B_136	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_136	serum_B_136	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_140	B_140	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_140	serum_B_140	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_144	B_144	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_144	serum_B_144	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	1			3				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_178	B_178	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_178	serum_B_178	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_182	B_182	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_182	serum_B_182	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	0			1				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_192	B_192	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_192	serum_B_192	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				3			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_196	B_196	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_196	serum_B_196	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_204	B_204	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_204	serum_B_204	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	36	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				3			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_212	B_212	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_212	serum_B_212	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_216	B_216	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_216	serum_B_216	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_220	B_220	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_220	serum_B_220	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	40	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				1			5				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_228	B_228	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_228	serum_B_228	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_232	B_232	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_232	serum_B_232	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	36	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_233	B_233	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_233	serum_B_233	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_240	B_240	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_240	serum_B_240	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_248	B_248	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_248	serum_B_248	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_255	B_255	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_255	serum_B_255	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_267	B_267	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_267	serum_B_267	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	34	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_282	B_282	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_282	serum_B_282	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			positive			trastuzumab	1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_290	B_290	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_290	serum_B_290	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_302	B_302	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_302	serum_B_302	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	34	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_346	B_346	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_346	serum_B_346	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_370	B_370	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_370	serum_B_370	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_408	B_408	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_408	serum_B_408	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_417	B_417	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_417	serum_B_417	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	33	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_421	B_421	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_421	serum_B_421	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_434	B_434	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_434	serum_B_434	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_445	B_445	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_445	serum_B_445	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_452	B_452	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_452	serum_B_452	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_467	B_467	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_467	serum_B_467	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	19	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_471	B_471	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_471	serum_B_471	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_475	B_475	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_475	serum_B_475	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_488	B_488	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_488	serum_B_488	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	35	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			5				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_519	B_519	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_519	serum_B_519	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_543	B_543	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_543	serum_B_543	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	1			5				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_547	B_547	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_547	serum_B_547	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_562	B_562	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_562	serum_B_562	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				0			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_570	B_570	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_570	serum_B_570	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	1			5				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_578	B_578	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_578	serum_B_578	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			3				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_582	B_582	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_582	serum_B_582	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			5				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_588	B_588	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_588	serum_B_588	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				0			5				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_604	B_604	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_604	serum_B_604	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			5				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_607	B_607	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_607	serum_B_607	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_616	B_616	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_616	serum_B_616	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				2			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_695	B_695	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_695	serum_B_695	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_713	B_713	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_713	serum_B_713	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				1			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_719	B_719	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_719	serum_B_719	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_722	B_722	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_722	serum_B_722	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_740	B_740	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_740	serum_B_740	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				1			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_744	B_744	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_744	serum_B_744	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_756	B_756	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_756	serum_B_756	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_760	B_760	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_760	serum_B_760	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	35	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_768	B_768	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_768	serum_B_768	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_776	B_776	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_776	serum_B_776	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_778	B_778	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_778	serum_B_778	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_792	B_792	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_792	serum_B_792	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_796	B_796	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_796	serum_B_796	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_812	B_812	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_812	serum_B_812	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				1			1				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_816	B_816	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_816	serum_B_816	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_820	B_820	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_820	serum_B_820	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_824	B_824	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_824	serum_B_824	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_828	B_828	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_828	serum_B_828	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_832	B_832	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_832	serum_B_832	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_836	B_836	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_836	serum_B_836	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_860	B_860	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_860	serum_B_860	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_864	B_864	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_864	serum_B_864	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_907	B_907	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_907	serum_B_907	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_916	B_916	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_916	serum_B_916	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_940	B_940	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_940	serum_B_940	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_944	B_944	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_944	serum_B_944	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_960	B_960	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_960	serum_B_960	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_972	B_972	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_972	serum_B_972	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_982	B_982	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_982	serum_B_982	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_988	B_988	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_988	serum_B_988	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	18	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1000	B_1000	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1000	serum_B_1000	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	32	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1001	B_1001	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1001	serum_B_1001	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	18	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1016	B_1016	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1016	serum_B_1016	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1044	B_1044	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1044	serum_B_1044	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1060	B_1060	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1060	serum_B_1060	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1123	B_1123	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1123	serum_B_1123	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1135	B_1135	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1135	serum_B_1135	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	33	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1141	B_1141	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1141	serum_B_1141	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	1			1				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1153	B_1153	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1153	serum_B_1153	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1157	B_1157	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1157	serum_B_1157	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1190	B_1190	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1190	serum_B_1190	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	39	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				2			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1209	B_1209	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1209	serum_B_1209	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1229	B_1229	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1229	serum_B_1229	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1402	B_1402	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1402	serum_B_1402	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1406	B_1406	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1406	serum_B_1406	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1417	B_1417	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1417	serum_B_1417	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1440	B_1440	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1440	serum_B_1440	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1463	B_1463	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1463	serum_B_1463	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	0			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1488	B_1488	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1488	serum_B_1488	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1499	B_1499	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1499	serum_B_1499	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				0			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1505	B_1505	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1505	serum_B_1505	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				1			3				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1521	B_1521	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1521	serum_B_1521	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1540	B_1540	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1540	serum_B_1540	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1560	B_1560	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1560	serum_B_1560	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1580	B_1580	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1580	serum_B_1580	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				1			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1611	B_1611	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1611	serum_B_1611	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive							negative				0			1				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1615	B_1615	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1615	serum_B_1615	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1619	B_1619	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1619	serum_B_1619	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1624	B_1624	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1624	serum_B_1624	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1663	B_1663	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1663	serum_B_1663	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1665	B_1665	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1665	serum_B_1665	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1671	B_1671	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1671	serum_B_1671	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	32	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1679	B_1679	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1679	serum_B_1679	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	34	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1695	B_1695	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1695	serum_B_1695	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1699	B_1699	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1699	serum_B_1699	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1711	B_1711	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1711	serum_B_1711	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1715	B_1715	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1715	serum_B_1715	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1719	B_1719	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1719	serum_B_1719	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	32	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1723	B_1723	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1723	serum_B_1723	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	44	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1733	B_1733	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1733	serum_B_1733	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	32	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				2			5				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1739	B_1739	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1739	serum_B_1739	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			positive			trastuzumab	0			1				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1747	B_1747	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1747	serum_B_1747	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1755	B_1755	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1755	serum_B_1755	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1764	B_1764	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1764	serum_B_1764	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1771	B_1771	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1771	serum_B_1771	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1795	B_1795	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1795	serum_B_1795	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1807	B_1807	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1807	serum_B_1807	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1815	B_1815	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1815	serum_B_1815	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1819	B_1819	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1819	serum_B_1819	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1827	B_1827	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1827	serum_B_1827	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1831	B_1831	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1831	serum_B_1831	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1835	B_1835	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1835	serum_B_1835	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1847	B_1847	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1847	serum_B_1847	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1867	B_1867	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1867	serum_B_1867	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1871	B_1871	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1871	serum_B_1871	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_1875	B_1875	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1875	serum_B_1875	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				2			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1883	B_1883	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1883	serum_B_1883	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	18	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			1				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_1975	B_1975	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_1975	serum_B_1975	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				2			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_2023	B_2023	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2023	serum_B_2023	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			negative				0			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_2031	B_2031	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2031	serum_B_2031	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				1			5				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_2241	B_2241	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2241	serum_B_2241	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_2423	B_2423	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2423	serum_B_2423	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_2588	B_2588	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2588	serum_B_2588	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative							negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_2593	B_2593	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2593	serum_B_2593	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_2597	B_2597	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2597	serum_B_2597	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_2605	B_2605	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2605	serum_B_2605	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_2841	B_2841	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2841	serum_B_2841	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	33	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_2846	B_2846	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2846	serum_B_2846	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			3				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_2879	B_2879	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2879	serum_B_2879	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_2892	B_2892	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_2892	serum_B_2892	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	38	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			3				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_3006	B_3006	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3006	serum_B_3006	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3015	B_3015	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3015	serum_B_3015	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3022	B_3022	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3022	serum_B_3022	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_3031	B_3031	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3031	serum_B_3031	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3041	B_3041	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3041	serum_B_3041	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3052	B_3052	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3052	serum_B_3052	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3064	B_3064	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3064	serum_B_3064	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_3074	B_3074	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3074	serum_B_3074	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3077	B_3077	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3077	serum_B_3077	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive							negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_3087	B_3087	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3087	serum_B_3087	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	35	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3098	B_3098	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3098	serum_B_3098	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	32	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive							negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3108	B_3108	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3108	serum_B_3108	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_3116	B_3116	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3116	serum_B_3116	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3126	B_3126	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3126	serum_B_3126	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	22	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	2			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3135	B_3135	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3135	serum_B_3135	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	31	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3145	B_3145	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3145	serum_B_3145	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3319	B_3319	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3319	serum_B_3319	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3329	B_3329	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3329	serum_B_3329	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				2			positive			trastuzumab	1			3				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_3334	B_3334	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3334	serum_B_3334	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	26	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3341	B_3341	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3341	serum_B_3341	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	35	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3350	B_3350	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3350	serum_B_3350	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3364	B_3364	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3364	serum_B_3364	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3375	B_3375	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3375	serum_B_3375	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	20	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			positive			trastuzumab	3			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3388	B_3388	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3388	serum_B_3388	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			1				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3393	B_3393	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3393	serum_B_3393	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	29	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3402	B_3402	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3402	serum_B_3402	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3412	B_3412	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3412	serum_B_3412	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	36	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	1			5				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_3482	B_3482	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3482	serum_B_3482	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3488	B_3488	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3488	serum_B_3488	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				3			positive			trastuzumab	1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_3493	B_3493	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3493	serum_B_3493	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	35	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			negative				2			positive			trastuzumab	0			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_3495	B_3495	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3495	serum_B_3495	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	28	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3501	B_3501	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3501	serum_B_3501	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	19	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			negative				3			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_3506	B_3506	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3506	serum_B_3506	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				1			2				before neoadjuvant therapy			validation cohort			pathologic complete response		serum_B_3511	B_3511	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3511	serum_B_3511	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	24	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				1			3				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3518	B_3518	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3518	serum_B_3518	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	30	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3522	B_3522	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3522	serum_B_3522	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	23	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				3			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3527	B_3527	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3527	serum_B_3527	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	27	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3556	B_3556	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3556	serum_B_3556	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	21	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				2			negative				1			4				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3592	B_3592	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3592	serum_B_3592	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	25	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	postmenopause			positive				3			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		serum_B_3620	B_3620	Homo sapiens	NCBITAXON	http://purl.obolibrary.org/obo/NCBITaxon_9606	female	breast cancer	sample collection	non fasting	B_3620	serum_B_3620	blood serum	BTO	http://purl.obolibrary.org/obo/BTO_0000133	18	kilogram per square meter	UO	http://purl.obolibrary.org/obo/UO_0000086	premenopause			positive				2			negative				0			2				before neoadjuvant therapy			validation cohort			no pathologic complete response		